CTLA4 and immune system disorder: Heterozygous CTLA4 mutations have been implicated in the emergence of a complex immune dysregulation syndrome with features of autoinflammation, autoimmunity and immunodeficiency [12,13,31,32], as well as an increased risk of cancer development [32].